Filing Flows › Cryo Cell International (CCEL) › Q3 FY26
Cryo Cell International (CCEL) Q3 FY26 earnings results (third quarter fiscal 2026)
10-Q filed Oct 9, 2026
Cryo Cell International (CCEL) reported revenue of $7.8M for the third quarter fiscal 2026 (Q3 FY26), 0% from a year earlier and +0.6% from the quarter before. Operating margin was 28.0%, net earnings $1.3M (16.2% of revenue).
Cryo Cell International, Q3 FY26: revenue $7.8M (0% year over year), operating margin 28.0%, net earnings $1.3M, operating cash flow $1.1M. The chart follows the revenue to costs, profit and cash.
| Q3 FY26 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $7.8M | +0.6% | 0% |
| Operating profit | $2.2M | +83% | +15% |
| Net earnings | $1.3M | +129% | +70% |
| Operating cash flow | $1.1M | -38% | -55% |
| Free cash flow | $1.0M | -43% | -58% |
What changed
Revenue was $7.8M in Q3 FY26, roughly flat year over year and up 1% from the previous quarter. Processing and Storage Fees was the largest line at 98% of revenue. Processing and Storage Fees lost $171K year over year (down 2%), 13373% of the total change.
Operating profit was $2.2M, a 28.0% margin (up 3.8 points year over year). Total costs fell 5% while revenue was flat. Net earnings were $1.3M, up 70% year over year. The effective tax rate was 30.4%.
Operating cash flow was $1.1M (down 55% year over year), 90% of net earnings. Non-cash charges added back $241K of depreciation and amortization and $93K of share-based compensation. Working capital and other items used $462K. Capital expenditures of $102K left free cash flow of $1.0M.
Questions
What was Cryo Cell International's revenue in the third quarter fiscal 2026?
Cryo Cell International (CCEL) reported revenue of $7.8M for the third quarter fiscal 2026 (Q3 FY26), 0% from a year earlier and +0.6% from the quarter before.
Was Cryo Cell International profitable in the third quarter fiscal 2026?
Operating profit was $2.2M (28.0% of revenue) and net earnings $1.3M.